peripheral artery disease, and renal failure both in men and in women.
6-9 The NATPOL2011 study showed that about 10.5 million patients suffer from high BP in Poland, which represents 32% of the adult population. This number includes 9.5 million people aged from 18 to 79 years and almost 1 million aged 80 years or older.
One of the factors involved in the regulation of BP is the α 2A -adrenergic receptor. Its activation leads to BP lowering due to the inhibition of norepinephrine secretion from adrenergic fibers, which is controlled by a negative feedback.
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The α 2A -adrenergic receptor belongs to the family of receptors coupled to the heterotrimeric INTRODUCTION Essential hypertension is the most common cardiovascular disease, affecting from 20% to 50% of the adult population in developed countries.
1 Moreover, it accounts for 95% of all cases of hypertension 2 and is influenced both by environmental and by genetic factors. 3 Studies of families, as well as of monozygotic and dizygotic twins, have indicated that hypertension has a strong genetic component and that the coefficient of hypertension heritability ranges from 20% to 55%.
4,5
Numerous epidemiological studies have shown that elevated blood pressure (BP) is a risk factor for coronary artery disease, heart failure, stroke, (mg/dl), low-density lipoprotein (LDL) cholesterol (mg/dl), and triglyceride (mg/dl) levels. The clinical characteristics of the study and control groups are provided in TABLE 1.
The control group consisted of 302 healthy Polish residents unrelated to patients. The inclusion criteria for the control group included the presence of normal BP confirmed by at least 2 separate BP measurements on 2 different days of hospitalization and no history of antihypertensive treatment. All control participants were selected randomly. The age of less than 18 years was the exclusion criterion both for the study and control groups.
The study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Bioethics Committee of the Medical University of Lodz, Łódź, Poland.
DNA extraction and genotype determination Venous blood from all individuals was collected in vials containing sodium citrate at a concentration of 3.2% (Sarstedt, Nümbrecht, Germany). Samples were stored at -20°C until DNA isolation. Genomic DNA was isolated from blood leukocytes using a standard method (phenol/chloroform) or a Chemagic DNA Blood250 Kit (PerkinElmer, Waltham, Massachusetts, United States). The samples were examined using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, which was performed in a 25-µl volume containing 2.5 µl of 10 × PCR buffer (Bioron, Ludwigshafen, Germany), 1U DFS-Taq DNA Polymerase (Bioron, Ludwigshafen, Germany), 2 µl of 2 mM dNTP MIX (Thermo Scientific, Massachusetts, United States), 0.2 µl of 20 µM each primer (Genomed, Warsaw, Poland), 3 µl of extracted DNA, and 16.3 µl of distilled water. The PCR reactions were conducted in a Biometra T professional thermocycler (Analytik Jena Company, Jena, Germany). After an initial denaturation of 95°C for 5 minutes, the following cycle was performed 30 times: denaturation cycle, 95°C for 30 seconds; annealing, at a G i protein, which consists of α, β, and γ subunits. To date, 5 different Gβ subunits and 12 different Gγ subunits have been identified, 11 yielding 60 possible combinations of Gβγ dimers. However, biochemical studies have shown that the formation of a functional dimer does not occur randomly. 12,13 Studies based on Sf9 insect cells have indicated that β3 subunits and γ5 subunits interact with one another to form a functional βγ dimer associated with the Gα i 2 subunit of the G protein.
14 Richardson and Robishaw 15 reported that the β3γ5 dimer with the Gα i subunit demonstrates a substantially greater coupling with the recombinant α 2A -adrenergic receptor than other dimer combinations. The structure of the G-protein subunit is the key to achieve a physiological effect as a result of receptor stimulation. Dysfunction of the signal transduction pathway from the α 2A -adrenergic receptor may disrupt the physiological response and lead to the development of essential hypertension.
The aim of this study was to determine whether there is any association between the presence of essential hypertension and the occurrence of selected polymorphic variants of the GNG5 gene coding the G-protein γ5 subunit in the Polish population. We tested 5 polymorphisms of the GNG5 gene: 3 in the coding region (Ser6Gly, rs11559300; Leu48Met, rs199705300; Thr56Ile, rs61754630) and 2 in the promoter region (rs13093, recognized by the Sp1 transcription factor, and rs41284589, recognized by the Nfr1 transcription factor).
PATIENTS AND METHODS Subjects
The study group consisted of 536 patients with a diagnosis of essential hypertension based on the 2013 European Society of Hypertension and European Society of Cardiology guidelines for the management of arterial hypertension, 16 who had been treated with antihypertensive medications for at least 30 days before admission. All patients were Caucasians. Additional data obtained from hospital records included total cholesterol (mg/ dl), high-density lipoprotein (HDL) cholesterol The HWE was tested to compare expected and observed genotype frequencies using the χ 2 test. The distribution of the rs13093 polymorphism was consistent with the HWE (P = 0.2707), while the frequency of rs41284589 alleles significantly deviated from the expected value. No polymorphic variants for rs11559300, rs199705300, or rs61754630 were observed either in the study or control group.
The frequencies of the genotypes and minor alleles for rs13093 and rs41284589 between the temperature specific for the individual SNP for 30 seconds; elongation, 72°C for 30 seconds; final extension, 72°C for 10 minutes; and then cooling to 16°C. The specific conditions for genotyping, including the choice of primer (Genomed) and annealing temperature and enzymes (Thermo Scientific), are presented in TABLE 2. The digestion products were separated by polyacrylamide gel electrophoresis in a Biometra Minigel-Twin (Analytik Jena Company) and visualized after staining with ethidium bromide (UVP PhotoDoc-It™ Imaging System, Upland, California, United States).
Statistical analysis Owing to its nonnormal distribution, age was expressed as means and standard deviations. The frequency of alleles was tested against the Hardy-Weinberg equilibrium (HWE). The Yates-corrected χ 2 test was used for data comparisons. A logistic regression analysis was performed to determine the relationship between individual factors and the occurrence of essential hypertension. Univariate comparisons were performed for all analyzed factors, and factors with P values lower than 0.15 were entered 19 Moreover, increased noradrenaline turnover was observed in mice expressing a mutant α 2A -receptor (α 2A -D79N).
20 As coupling the receptor with an appropriately-composed G-protein subunit is required for the correct functioning of G protein-coupled receptor signaling pathways, this functioning may be disrupted by the presence of an SNP in the γ subunit of the G protein.
The G-protein γ5 subunit is a human protein encoded by the GNG5 gene located on the short arm of chromosome 1 (1p22.3).
21 GNG5 spans 6kb and consists of 4 exons and 3 introns. The coding region is localized at the 3'-end of exon 2 and in the most part of exon 3. 21 The analysis by PROMOTER SCAN (version 1.7) and a related study by Liu et al 22 indicated that the functional promoter region of GNG5 lies within the ranges from -725 to -456 and from -342 to -92.
23
Our findings indicate that the examined SNPs (rs11559300, rs199705300, and rs61754630) are not present in the G-protein γ5 subunit coding region within the Polish population. However, they do suggest that the carriers of the A allele of -195 C/A (rs13093) in the promoter region of the GNG5 gene is associated with the risk of essential hypertension more than 2.9-fold greater than study and control groups were compared, and the results are presented in TABLE 3. As rs41284589 did not meet the HWE in the control group, the subsequent multivariate analysis included only rs13093 (TABLE 4) . Owing to the low percentage of polymorphic genotypes, the statistical analysis included the distributions of wild homozygotes vs mutant homozygotes and heterozygotes. A significant relationship was observed between the presence of rs13093 in the GNG5 gene and the risk of essential hypertension.
Analysis in the study group The statistical analysis of rs13093, rs41284589, and the clinical parameters in the study group showed that the T allele of rs41284589 (C/T) is associated with elevated levels of total cholesterol, LDL cholesterol, and triglycerides, and decreased levels of HDL cholesterol, regardless of sex (TABLE 5). These parameters were entered into the multivariate analysis based on the multivariate backward-stepwise model, which showed that the T allele of the rs41284589 polymorphism (C/T) protects against elevated blood triglyceride levels (OR, 0.32; 95% CI, 0.1-0.9) DISCUSSION Essential hypertension is the most common cardiovascular disease worldwide. The results of the present study indicate that rs13093 is a significant risk factor for essential hypertension in the Polish population, independent of primary hypertension risk factors.
In the sympathetic nervous system, 9 adrenergic receptor subtypes are activated by adrenaline and noradrenaline, but only the α 2 -adrenergic receptor has been implicated as an inhibitory hypertension and may help assess the risk profile in hypertensive patients, but further studies are needed to precisely define the effect of the A allele on the prognosis of these patients.
that observed in carriers of the C allele among the Polish population (OR, 2.91; 95% CI, 1.68-5.05). The rs13093 SNP is located in the recognition sequence of the Sp1 transcription factor. Sp1 is associated with many other transcription factors and can regulate the expression of TATA box--containing promoters, as well as those which do not contain the cassette. 24 The presence of the rs13093 (C >A) SNP in the recognition sequence of the Sp1 transcription factor may result in the loss of consensus sequences for Sp1 in this area, resulting in low levels of GNG5 mRNA and γ5 protein.
An insufficient amount of γ5 protein prevents the correct coupling of the G-protein complex (G α(i)2 with β3γ5) with the α 2A -adrenergic receptor. All the above may lead to the α 2A -adrenergic receptor displaying impaired hypotensive effects.
Interestingly, the multivariate analysis performed in the study group indicated that the T allele of the rs41284589 polymorphism may protect against elevated blood triglyceride levels (OR, 0.32; 95% CI, 0.1-0.9). The -152C/T polymorphism (rs41284589) occurs in the GNG5 promoter sequence recognized by transcription factor Nrf1. It is hypothesized that this polymorphism may influence the level of the GNG5 gene expression. The loss of consensus sequences for the Nrf1 transcription factor in the GNG5 gene may lead to reduced levels of GNG5 mRNA, resulting in reduced γ5 protein levels. In turn, as mentioned earlier, an insufficient amount of the γ5 protein prevents the G-protein complex (G α(i)2 with β3γ5) from coupling correctly with the α 2A -adrenergic receptor.
The hypotensive effect of the α 2A -adrenergic receptor causes numerous physiological responses, including the suppression of insulin release from pancreatic β cells. 25 Insulin is a major regulator of lipoprotein lipase (LPL) activity in adipose tissue. LPL hydrolyzes triglycerides present in the circulating blood lipoproteins, especially in chylomicrons and lipoproteins of very low density.
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During adipocyte differentiation, insulin increases LPL gene transcription. In mature adipocytes or adipose tissue, insulin stimulates LPL activity by increasing the level of LPL mRNA and regulating LPL through both posttranscriptional and posttranslational mechanisms. [27] [28] [29] This mechanism of action could explain the reduced levels of triglycerides in patients with the T allele of SNP rs41284589 (C/T).
The study has 1 important limitation-it included a relatively small group of subjects; therefore, it is necessary to confirm these results in a larger cohort. Nevertheless, the study participants belonged to the same ethnic group, which arguably strengthens the results. Another strength of the study is the fact that this is the first analysis of the association between the rs13093 polymorphism and the risk of essential hypertension.
In conclusion, the results of this study confirm the necessity to look closer into the role of this polymorphism in the GNG5 expression. Carrying the A allele at -195 C/A (rs13093) may be a potential genetic factor for primary essential
